Cargando…
Targeting newly identified ERβ/TGF‐β1/SMAD3 signals with the FDA‐approved anti‐estrogen Faslodex or an ERβ selective antagonist in renal cell carcinoma
Renal cell carcinoma (RCC) has the third highest mortality rate among urological tumors, and 20–30% of RCC patients present with metastatic RCC at the time of diagnosis. Although recent studies have indicated that estrogen receptor β (ERβ) could play promoting roles in RCC progression, the detailed...
Autores principales: | Song, Wenbin, He, Dalin, Chen, Yule, Yeh, Chiuan‐Ren, Hsu, Iawen, Huang, Qingbo, Zhang, Xu, Chang, Luke Sien‐Shih, Zuo, Li, Chen, Jiasheng, Doersch, Karen M., Chang, Chawnshang, Li, Lei, Yeh, Shuyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275262/ https://www.ncbi.nlm.nih.gov/pubmed/30171816 http://dx.doi.org/10.1002/1878-0261.12377 |
Ejemplares similares
-
Targeting the ERβ/Angiopoietin-2/Tie-2 signaling-mediated angiogenesis with the FDA-approved anti-estrogen Faslodex to increase the Sunitinib sensitivity in RCC
por: Gu, Junfei, et al.
Publicado: (2020) -
Recruited mast cells in the tumor microenvironment enhance bladder cancer metastasis via modulation of ERβ/CCL2/CCR2 EMT/MMP9 signals
por: Rao, Qun, et al.
Publicado: (2015) -
Infiltrating neutrophils promote renal cell carcinoma progression via VEGFa/HIF2α and estrogen receptor β signals
por: Song, Wenbin, et al.
Publicado: (2015) -
R-2HG downregulates ERα to inhibit cholangiocarcinoma via the FTO/m6A-methylated ERα/miR16-5p/YAP1 signal pathway
por: Gao, Yuan, et al.
Publicado: (2021) -
Infiltrated pre-adipocytes increase prostate cancer metastasis via modulation of the miR-301a/androgen receptor (AR)/TGF-β1/Smad/MMP9 signals
por: Xie, Hongjun, et al.
Publicado: (2015)